Camrelizumab may be approved as 3rd line treatment fot r/r cHL in the coming days. 五月 06, 2019 In 2019.5.5, the NDA left CDE to NMPA for the final approval. Finally it will be approved in the coming days soon. 标签 恒瑞 获批 上市 Camrelizumab PD-1 评论
评论